| Product Code: ETC8663234 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Norway`s blood plasma derivative import market in 2024 saw significant contributions from top exporters such as Germany, Switzerland, USA, Ireland, and Belgium. With a moderate Herfindahl-Hirschman Index (HHI), the market remained competitive. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 4.37%, indicating steady expansion. Moreover, the growth rate spiked to 13.55% from 2023 to 2024, showcasing a rapid surge in import shipments. This data suggests a promising outlook for Norway`s blood plasma derivative import market, driven by strong partnerships with key exporting countries.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Norway Blood Plasma Derivative Market Overview |
3.1 Norway Country Macro Economic Indicators |
3.2 Norway Blood Plasma Derivative Market Revenues & Volume, 2021 & 2031F |
3.3 Norway Blood Plasma Derivative Market - Industry Life Cycle |
3.4 Norway Blood Plasma Derivative Market - Porter's Five Forces |
3.5 Norway Blood Plasma Derivative Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Norway Blood Plasma Derivative Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Norway Blood Plasma Derivative Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Norway Blood Plasma Derivative Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring plasma-derived therapies |
4.2.2 Technological advancements in blood plasma collection and processing techniques |
4.2.3 Growing demand for plasma-derived products in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for plasma collection and processing |
4.3.2 Limited availability of plasma donors |
4.3.3 High costs associated with plasma derivative products |
5 Norway Blood Plasma Derivative Market Trends |
6 Norway Blood Plasma Derivative Market, By Types |
6.1 Norway Blood Plasma Derivative Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Norway Blood Plasma Derivative Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Norway Blood Plasma Derivative Market Revenues & Volume, By Albumin, 2021- 2031F |
6.1.4 Norway Blood Plasma Derivative Market Revenues & Volume, By Factor VII, 2021- 2031F |
6.1.5 Norway Blood Plasma Derivative Market Revenues & Volume, By Factor IX concentrate, 2021- 2031F |
6.1.6 Norway Blood Plasma Derivative Market Revenues & Volume, By Anti-coagulation factor, 2021- 2031F |
6.1.7 Norway Blood Plasma Derivative Market Revenues & Volume, By Rh immunoglobulin, 2021- 2031F |
6.1.8 Norway Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Norway Blood Plasma Derivative Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Norway Blood Plasma Derivative Market Revenues & Volume, By Immunodeficiency Diseases, 2021- 2031F |
6.2.3 Norway Blood Plasma Derivative Market Revenues & Volume, By Bleeding Disorders, 2021- 2031F |
6.2.4 Norway Blood Plasma Derivative Market Revenues & Volume, By Liver Conditions, 2021- 2031F |
6.2.5 Norway Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Norway Blood Plasma Derivative Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Norway Blood Plasma Derivative Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Norway Blood Plasma Derivative Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Norway Blood Plasma Derivative Market Revenues & Volume, By Transfusion Centers, 2021- 2031F |
7 Norway Blood Plasma Derivative Market Import-Export Trade Statistics |
7.1 Norway Blood Plasma Derivative Market Export to Major Countries |
7.2 Norway Blood Plasma Derivative Market Imports from Major Countries |
8 Norway Blood Plasma Derivative Market Key Performance Indicators |
8.1 Number of new plasma-derived products introduced in the market |
8.2 Rate of adoption of plasma-derived therapies in clinical settings |
8.3 Investment in research and development for plasma-derived products |
8.4 Percentage of plasma supply meeting regulatory standards |
8.5 Patient satisfaction and outcomes with plasma-derived therapies |
9 Norway Blood Plasma Derivative Market - Opportunity Assessment |
9.1 Norway Blood Plasma Derivative Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Norway Blood Plasma Derivative Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Norway Blood Plasma Derivative Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Norway Blood Plasma Derivative Market - Competitive Landscape |
10.1 Norway Blood Plasma Derivative Market Revenue Share, By Companies, 2024 |
10.2 Norway Blood Plasma Derivative Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here